The gut microbiota is a complex and plastic consortium of microorganisms that are intricately
connected with human physiology. The liver is a central immunological organ that is …

Primary sclerosing cholangitis (PSC) offers unique opportunities to explore the gut–liver axis
owing to the close association between liver disease and colonic inflammation. It is well …

Microbial cells significantly outnumber human cells in the body, and the microbial flora at
mucosal sites are shaped by environmental factors and, less intuitively, act on host immune …

This article reports on the sixth scientific workshop of the European Crohn's and Colitis
Organisation [ECCO] on the pathogenesis of extraintestinal manifestations [EIMs] in …

T cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy of immature T
lymphocytes, associated with higher rates of induction failure compared with those in B cell …

The principal targets for anti-chemokine therapy in inflammatory bowel disease (IBD) have
been the receptors CCR9 and CXCR3 and their respective ligands CCL25 and CXCL10 …

Celiac disease (CD) is an immune-mediated disorder triggered by gluten exposure. The
contribution of the adaptive immune response to CD pathogenesis has been extensively …

The gut microbiota consists of a dynamic multispecies community of bacteria, fungi, archaea,
and protozoans, playing a fundamental role in the induction, training, and function of the …

Background Recently, studies have suggested a role for the gut microbiota in epilepsy. Gut
microbial changes during ketogenic diet (KD) treatment of drug-resistant epilepsy have been …

Inflammatory bowel disease (IBD) includes Crohn's disease and ulcerative colitis. Each
disease is characterized by a diverse set of potential manifestations, which determine …